GS1: Geography     

GS2: Health

  • "Government Launches Mission COVID Suraksha to accelerate Indian COVID-19 Vaccine Development (PIB)" The COVID-19 Vaccine development Mission with end-to-end focus from preclinical development through clinical development and manufacturing and regulatory facilitation for deployment, would consolidate all available and funded resources towards an accelerated product development. This will help accelerate development of approx. 5-6 vaccine candidates and ensure that these are brought closer to licensure and introduction in market for consideration of regulatory authorities for introduction in public health systems, to combat further spread of COVID infection.

GS2: International Relations    

GS3: Internal Security  

GS3: Science & Technology